Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial

BACKGROUND: Atrial fibrillation (AF) is a complex cardiac arrhythmia in clinical practice with increasing incidence. However, the effects of statins on patients with AF are not quite clear. HYPOTHESIS: To investigate the protective effect of calcium channel blocker (CCB) and valsartan combined fluva...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhiqiang, Yang, Yu, Wang, Jianwei, Dong, Zhaojie, Niu, Xiaowei, Liu, Enzhao, Liu, Tong, Li, Lifeng, Liang, Yingzi, Li, Guangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724225/
https://www.ncbi.nlm.nih.gov/pubmed/33103770
http://dx.doi.org/10.1002/clc.23487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724225/
https://www.ncbi.nlm.nih.gov/pubmed/33103770
http://dx.doi.org/10.1002/clc.23487

Ejemplares similares